Single-fraction or multi-fraction SBRT for oligometastatic disease? EORTC SPRINT is exploring whether fewer treatment sessions could deliver the same efficacy while reducing burden for patients and healthcare systems. #EORTC #SPRINT #ESTRO #E²-RADIatE #RadiationOncology #SBRT

📢 The ENA 2026 programme is now online! 📍Barcelona, Spain | 18-20 Nov 2026 🔗 https://event.eortc.org/ena2026/programme/ American Association for Cancer Research (AACR) & National Cancer Institute #CancerResearch #Oncology

EORTC is running the 20km of Brussels 🏃‍♂️ Together with ECRF, we’re supporting independent cancer research. 💙 Every donation helps support research that advances cancer care Join us 👉 Donate here: donate.eortcresearchfund.org/main/~my-don... #RunForEORTC #ECRF #CancerResearch #ClinicalTrials

🧪 This Bladder Cancer Awareness Month, discover STARBURST 1 (EORTC-2418), advancing precision research in muscle-invasive bladder cancer under the SPECTA platform. Many thanks to the supporters contributing to this important research. #EORTCgenitourinary #BladderCancer

📢 New Lung Cancer publication from the EORTC Lung Cancer Group. Findings show targeted therapy is commonly used upfront in asymptomatic brain metastases, while approaches vary in symptomatic cases. Combination strategies are frequent in oligoprogression. 👉 Read more: www.eortc.org/publications/

📢 EORTC is hiring a Clinical Research Associate (CRA) to support international clinical trials in oncology. Based in Brussels, the role involves collaboration with investigators and study teams across Europe. 👉 Apply: www.eortc.org/job/clinical... #ClinicalTrials #Oncology #Hiring

📢 Late Rate Deadline tomorrow! Final chance to join #STATS2026 and strengthen your understanding of clinical trial statistics. 📅 9-12 June 2026 👉 Apply now: https://www.eortc.org/event/stats2026/#STATS2026 #CancerResearch #ClinicalTrials #StatisticalMethods

New EJC publication analysing 19 GI cancer trials (2010–2023) from EORTC & Unicancer using the PRECIS‑2 framework. Findings show restrictive eligibility, moderate use of patient-centred endpoints, and pragmatic primary analyses. 🔗 https://www.ejcancer.com/article/S0959-8049(26)00552-6/fulltext

📊 Why join #STATS2026? Get a clear and practical understanding of clinical trial statistics, without unnecessary complexity. 📅 9-12 June 2026 👉 Register now: https://www.eortc.org/event/stats2026/#STATS2026? #CancerResearch #ClinicalTrials #StatisticsForResearch #ClinicalResearch

New from @eortc.org #QualityofLife Group 📢 This study introduces novel time‑dynamic machine learning models to predict impaired HRQoL in early #BreastCancer, enabling more timely, targeted care — while highlighting the need for fair AI. 👉 www.eortc.org/publications/ #CancerCare @jmirpub.bsky.social

🙌 New article from @ihieurope.bsky.social highlighting #SISAQOL, an international initiative co-led by EORTC & @boehringerglobal.bsky.social to improve how #QualityofLife data are analysed & interpreted in cancer clinical trials. An important step for patient‑centred research. 👇 #ClinicalTrialsDay

Clinical trials play a key role in the development and approval of new medicines. EORTC CEO Denis Lacombe explains their purpose and importance in this video. 👇

On #ClinicalTrialsDay, EORTC announces the Summit for Clinical Cancer Research (23–24 March 2027, Brussels). Bringing stakeholders together to address trial methodology, QoL, AI and global policy in cancer research. 🎥 www.youtube.com/watch?v=TRif... 🔗 Read more: www.eortc.org/blog/2026/05...

Princess Laetitia is running the Edinburgh Half-Marathon this Sunday to support independent clinical cancer research and EORTC’s mission. Support the initiative: https://donate.eortcresearchfund.org/edinburgh-half-marthon-2026/~my-donation #RunForResearch #RunForEORTC #CancerResearch #ECRF

Coming up today at #ESTRO26, Sarah Kelly will be presenting in the symposium session: “The future of RTQA in clinical trials and beyond.” 🔗 https://www.eortc.org/blog/2026/04/30/eortcs-presence-at-estro-2026/ 👇Don't miss it European Society for Radiotherapy and Oncology (ESTRO) #ESTRO26#Radiotherapy

As #ESTRO26 continues today, EORTC clinical research is featured in two proffered papers, focusing on key methodological and clinical aspects of radiotherapy trials, including outcomes and patient‑reported quality of life data. 👉 www.eortc.org/blog/2026/04... @estroradiotherapy.bsky.social

📢Final EORTC 22922/10925 trial results presented at #ESTRO26 20‑year data shows lymph node RT lowers breast cancer mortality but not overall survival, highlighting the need for very long‑term follow‑up. 👉 https://www.eortc.org/blog/2026/05/17/final-eortc-trial-results-estro-2026/

👏 Looking forward to the presentations from our @eortc.org Quality of Life Group members this weekend at #ESTRO2026! 🔗 More info: www.eortc.org/blog/2026/04... and ⬇️ #QualityofLife #GivingVoice2Patients #CancerResearch #EORTC

Also this weekend at #ESTRO26, EORTC will co‑lead a joint ESTRO–EORTC symposium on “Designing radiotherapy trials for the future generation,” focusing on the role of RTQA, protocol harmonisation, and evidence generation in radiotherapy clinical trials. 👉 eortc.org/blog/2026/04...

🔜 This weekend at #ESTRO26, EORTC proffered papers and a mini‑oral will present results from EORTC‑22922/10925 and OligoCare, covering SBRT, re‑irradiation, RTQA, quality of life and trial methodology. Thanks to authors and presenters! www.eortc.org/blog/2026/04... @estroradiotherapy.bsky.social

📢 EORTC at #ESTRO2026 From trials such as EORTC‑22922/10925 to OligoCare, EORTC research features across proffered papers, posters and sessions, including: ➡️a co‑led ESTRO–EORTC symposium and ➡️ a contribution on RTQA in clinical trials. 👉 www.eortc.org/blog/2026/04... #EORTC #Radiotherapy

🔎 Who is this course for? For non-statisticians in clinical research and statisticians new to trials, this course offers a practical understanding to clinical trial statistics! 📅 9-12 June 2026 👉 https://www.eortc.org/event/stats2026/ #STATS2026 #ClinicalResearch #StatisticalMethods

Princess Laetitia is running the Edinburgh Half-Marathon to support independent clinical cancer research. Improving cancer care also takes long-term commitment and teamwork across Europe. Support here: https://ow.ly/2WtO50YXCxz #RunForResearch #RunForEORTC #CancerResearch #ECRF

📢 Are you a PhD scientist in clinical research? Join EORTC and contribute to the design and conduct of international cancer trials and collaborative research programmes. 📍 Brussels 🔗 Apply: www.eortc.org/job/clinical... #EORTC #ClinicalResearch #ClinicalTrials

📢 Fellowship opportunity at EORTC in QoL! Are you a statistician or methodological researcher interested in how patient experience is captured in cancer trials? Join a project integrating PROs and adverse events to improve trial reporting. 🔗Apply: www.eortc.org/job/fellowsh... @qol.eortc.org

New from @eortc.org Quality of Life Group 📢 The study led by A. Moura & C. Simões Padilla combined quantitative data & patient narratives to identify key challenges & unmet needs for patients with anal cancer. 🔗 www.eortc.org/publications/ #QualityofLife #GivingVoice2Patients #CancerCare #AnalCancer

📢 We are hiring an Administrative Assistant in Brussels. A key role supporting Statistics, Scientific Direction & Reception in an international clinical research environment. 👉Apply here: https://ow.ly/4VvU50YV2nb #AdministrativeAssistant #ClinicalResearch #Brussels

📢 Registrations reminder! 💻 A practical introduction to statistics for cancer clinical trials, from design to analysis. 📅 9–12 June 2026 👉 https://www.eortc.org/event/stats2026/ #CancerResearch #ClinicalTrials #ClinicalResearch

For over 60 years, EORTC has led independent clinical cancer research worldwide. 4,200+ members | 74+ countries | 140+ studies | 222K+ patients 🔎 Learn more: https://www.eortc.org/impact/ ❤️ Support: https://donate.eortcresearchfund.org/edinburgh-half-marthon-2026/~my-donation

New ALTHEA publication This umbrella review maps validated tools to screen mental health and cognitive challenges in cancer patients & caregivers. EORTC is proud to be co‑author through its involvement in @althea-project.bsky.social. doi.org/10.1002/pon.... #EU4Health @europeancancer.bsky.social

📢 New EORTC COBRA results published in The Lancet Haematology: A PET scan after just one chemo cycle can guide personalised treatment in advanced Hodgkin lymphoma. Led by Prof. Martin Hutchings, Dr. Wouter Plattel & the EORTC Lymphoma Group. 🔗 https://ow.ly/IRQC50YSr8S

📢 Last chance to apply for the SISAQOL 2026 in‑person training in Zagreb. Hands‑on training on implementing SISAQOL recommendations, proudly supported by EORTC and @qol.eortc.org 👏 ⏳ Deadline to apply: 15 May 2026 🔗 More info: www.sisaqol-imi.org/sisaqol-trai... and below ⬇️ #SISAQOLtraining

📢 New EORTC–ESTRO OligoCare publication. Published in @TheLancetOncol, this third OligoCare consensus paper recommends primary endpoints for trials of MDT in oligometastatic cancer, supporting patient‑centred research. Read more: www.eortc.org/publications/ #ClinicalTrials #CancerResearch

📢 New publication: Academic clinical cancer trials as public good Read how independent research improves patient outcomes and strengthens healthcare systems. With contributions from Denis Lacombe (EORTC), Winette van der Graaf and Martin Stockler. 👉 www.eortc.org/blog/2026/04...

Princess Laetitia of Belgium will take part in the Edinburgh Half Marathon on 24 May 2026 to support independent clinical cancer research. Support the initiative: https://donate.eortcresearchfund.org/edinburgh-half-marthon-2026/~my-donation #RunForResearch #RunForEORTC #CancerResearch #ECRF

📢 Interested in RTQA, trial methodology, and innovation in radiotherapy? EORTC is recruiting an early‑career medical physicist for the EORTC/Andrée Dutreix Fellowship Programme, based in Brussels. 🗓️ Deadline: 31 May 2026 🔗 More info: eortc.org/job/fellowsh... #Fellowship

🆕 International study led by Micha Pilz presents @eortc.org QLU‑C10D country value sets for Belgium, Hungary, Portugal and the Republic of Korea, enabling cancer‑specific health utility measurement for economic evaluations in these countries. 🔗 doi.org/10.1007/s101... #QualityofLife #CancerResearch

📢 Two new European Journal of Cancer papers highlight the achievements of the EORTC Young & Early Career Investigator (Y‑ECI) Network. With over 1,200 members, the network fosters training, trial involvement and leadership development of early-career healthcare professionals.

We are deeply saddened by the passing of Martine Van Glabbeke (1951–2026). Martine dedicated 36 years to EORTC and was a cornerstone of the EORTC Sarcoma Group, shaping practice‑changing cancer trials worldwide. She will be deeply missed. Our heartfelt condolences to her family.

🚀 Registrations and abstract submissions are now open for #ENASymp26 Submit your research and join a global community in cancer drug development and translational research 👉 event.eortc.org/ena2026/ With @theaacr.bsky.social and the National Cancer Institute

🎉 First Patient In for #RENALUT The first patient has been enrolled in the EORTC‑2361 RENALUT trial at Centre François Baclesse (FR) by Prof. Florence Joly. A key milestone reflecting strong collaboration led by Study Coordinators E. Seront, L. Albiges, K. Goffin & B. Tombal. #EORTCgenitourinary

📢 We’re hiring a Clinical Research Physician Are you a Medical Doctor specialised in cancer care, with 5+ years’ experience as a medical specialist and hands‑on involvement in #ClinicalTrials or #MedicalMonitoring? 👉 Apply here: www.eortc.org/job/clinical... #CancerResearch

📢 Great things ahead! We’re thrilled to highlight the upcoming 7th EORTC #QualityofLife in Cancer Clinical Trials Conference, taking place 13–14 May 2027 in Madrid. Proud to support this important event shaping the future of HRQOL and PRO research.👇 #QoLConf27 #CancerResearch #ClinicalTrials

👏 Proud to support the SISAQOL 2026 pilot in-person training together with the @qol.eortc.org — an excellent opportunity for hands‑on learning on PRO & HRQoL endpoints in cancer trials. #SISAQOLtraining

📍Live from #EBCC15 in Barcelona! As a proud partner of EBCC, EORTC is excited to be here and part of the conversation shaping the future of breast cancer care. Come visit our booth to meet the team. We’d love to connect with you! See you there 👋 #CancerResearch #ClinicalTrials #Oncology

🤝 Strengthening international collaboration to advance high‑quality patient‑centred outcomes research. Proud to partner with Samsung Medical Center to further reinforce the quality of Korean versions of EORTC #QualityofLife questionnaires. More info and link👇 #CancerResearch #GivingVoice2Patients

🎗️It’s #KidneyCancerAwarenessMonth, a moment to highlight progress in kidney cancer research. Recently, we activated the first site for the RENALUT trial, advancing key research for metastatic clear cell renal cell carcinoma. 🔗Read more: www.eortc.org/blog/2026/02... #EORTCgenitourinary

We’ve just wrapped up the EORTC 2026 Strategy Meeting! Two inspiring days bringing global leaders together to strengthen independent, patient‑centred clinical cancer research. Grateful for the collaboration and insight. 🔜 Stay tuned! #EORTC #ClinicalResearch #CancerResearch

🆕 Published in The Oncologist: New results from the SPARTA (GIMEMA–EORTC 1621‑QLG‑LG) study examine quality of life and lifestyle behaviours in  long‑term AML survivors, offering essential insights for patient‑centred care. 🔗 www.eortc.org/publications/ #CancerResearch #AML #EORTC @qol.eortc.org

📩 MCCR 2026 Fellow notifications are on their way! Keep an eye on your inbox, and don’t forget to check your spam folder just in case. American Association for Cancer Research (AACR) ESMO - European Society for Medical Oncology #MCCR #CancerResearch #ClinicalTrialDesign